Highlights Abbott Laboratories

Equities

ABT

US0028241000

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
107.5 ^USD	+0.63%		+0.23%	-2.31%

Apr. 26	Dexcom's profit beats estimates on strong glucose monitor demand	RE
Apr. 26	Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dexcom's profit beats estimates on strong glucose monitor demand	Apr. 25	RE
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
Correction to Health Care Roundup Article	Apr. 18	DJ
Health Care Down After Abbott Earnings -- Health Care Roundup	Apr. 17	DJ
Sector Update: Health Care Stocks Retreating Late Afternoon	Apr. 17	MT
News Highlights : Top Company News of the Day - Wednesday at 3 PM ET	Apr. 17	DJ
S&P 500, Nasdaq dip as interest rate concerns, earnings weigh	Apr. 17	RE
Abbott Laboratories Raises Midpoint of 2024 Guidance After First-Quarter Beat	Apr. 17	MT
Top Stories at Midday: U.S. Bancorp, Abbott, Citizens Financial, First Horizon, Prologis, ASML, Travelers Report Earnings; Tesla Asks Shareholders Vote on Musk's Compensation; Eli Lilly Sleep Apnea Drug Trials Hit Primary Endpoints	Apr. 17	MT
News Highlights : Top Company News of the Day - Wednesday at 1 PM ET	Apr. 17	DJ
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET	Apr. 17	DJ
Wall St slips as dour earnings, chip stocks weigh	Apr. 17	RE
Sector Update: Health Care Stocks Advance Premarket Wednesday	Apr. 17	MT
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET	Apr. 17	DJ
Abbott: target ranges for 2024 tightened upwards	Apr. 17	CF
Abbott Laboratories' Q1 Adjusted Earnings Down, Revenue Up; 2024 Outlook Narrowed	Apr. 17	MT
Earnings Flash (ABT) ABBOTT Posts Q1 Revenue $9.96B, vs. Street Est of $9.87B	Apr. 17	MT
Earnings Flash (ABT) ABBOTT Posts Q1 EPS $0.98, vs. Street Est of $0.95	Apr. 17	MT
Abbott Laboratories Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 17	CI
Abbott Laboratories Provides Earnings Guidance for the Second Quarter and Full Year of 2024	Apr. 17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Abbott Laboratories

Equities

ABT

US0028241000

Highlights

Filters